{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-038598","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.644570+00:00","generated_at":"2026-06-08T05:22:50.384982+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Beauty Health CEO Andrew Stanleick departs; director Marla Beck named interim CEO","bullets":["Andrew Stanleick steps down as CEO and board member effective Nov 19, 2023; will advise through Dec 31, 2023.","Director Marla Beck appointed interim CEO from Nov 20, 2023, for a 6-month term; resigns from audit committee.","Beck co-founded Bluemercury; led it as CEO for 22 years including post-acquisition by Macy's.","Interim CEO compensation: $200K monthly base (min. 4 months), $500K RSUs ratably vesting over term, $400K change-in-control bonus.","Board has initiated a formal search for a permanent CEO; Saunders expresses confidence in strategy and long-term growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-038598","json":"https://secwatch.observer/filing/0001628280-23-038598.json","markdown":"https://secwatch.observer/filing/0001628280-23-038598.md","text":"https://secwatch.observer/filing/0001628280-23-038598.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/0001628280-23-038598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/skin-20231110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:22:50.384982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7ee25bc086","claim":"Andrew Stanleick departed as chief executive officer at SkinHealth Systems Inc..","evidence_excerpt":"Andrew Stanleick, who will step down from the role of chief executive officer of the Company, effective as of November 19, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/0001628280-23-038598-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"step down"},{"label":"Role","value":"chief executive officer"}],"fact_type":"executive_change"},{"claim_id":"b5d253f153","claim":"Marla Beck was appointed as interim chief executive officer at SkinHealth Systems Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of The Beauty Health Company (the “Company”) appointed Marla Beck, age 53, as interim chief executive officer of the Company (the “Interim CEO”), for a 6-month term (the “Term”) effective November 20, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/0001628280-23-038598-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim chief executive officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}